CDC updates TB test guidelines
This article was originally published in The Gray Sheet
Executive Summary
For the first time since 2000, the Centers for Disease Control and Prevention has updated its guidelines for the use of nucleic acid amplification tests to diagnose tuberculosis. CDC now recommends using NAA tests for patients with symptoms of pulmonary TB "for whom a diagnosis is being considered but not yet established." According to CDC, NAA tests can confirm pulmonary TB weeks earlier than the conventional test, leading to improved patient outcomes and increased opportunities to interrupt transmission
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.